The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
The meeting of the Russian Council of Experts for the use of the novel anabolic agent Forsteo®(teriparatide) to treat osteoporosis (OP) was held in Moscow on June 29, 2013. The meeting was attended by leading Russian OP specialists, including the members of the Russian Osteoporosis Association and i...
Saved in:
Main Author: | Olga Mikhailovna Lesnyak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/502 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Teriparatide in sequental treatment of osteoporosis in a patient with spinal muscular atrophy: a case report and literature review
by: Matej Rakusa, et al.
Published: (2025-09-01) -
A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis
by: Nitin Kapoor, et al.
Published: (2025-06-01) -
New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01) -
Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State
by: I. A. Skripnikova, et al.
Published: (2019-07-01) -
Resolution of the Council of Russian Experts: Apremilast, a phosphodiesterase 4 inhibitor, as a representative of a new class of small molecule compounds: Its place in the treatment of moderate or severe psoriasis and psoriatic arthritis
by: A. A. Kubanov
Published: (2017-03-01)